Biodexa Pharmaceuticals

BDRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.80

-$0.63 (-18.37%)

At close: Nov 2, 2026, 4:00 PM ET

$2.98

+$0.18 (+6.43%)

After-hours: Nov 2, 2026, 5:04 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q4 2025 Dec 31, 2025	Q2 2025 Jun 30, 2025	Q4 2024 Dec 31, 2024	Q2 2024 Jun 30, 2024	Q4 2023 Dec 31, 2023	Q2 2023 Jun 30, 2023	Q4 2022 Dec 31, 2022	Q2 2022 Jun 30, 2022	Q4 2021 Dec 31, 2021	Q2 2021 Jun 30, 2021
Cash & Equivalents	3.21M	8.52M	4.04M	1.67M	5.06M	5.97M	5.23M	2.84M	6.42M	10.06M	4.2M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	-698K	-837K	-993K	-1.15M	-1.25M
Receivables	3.44M	221.61K	4.49M	715K	1.92M	704K	2.04M	329K	1.24M	33K	1.4M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	462K	n/a	547K	n/a	n/a	n/a	1.02M	n/a	1.42M
Total Current Assets	6.65M	12.42M	8.99M	8.81M	7.52M	7.03M	7.26M	4.69M	8.69M	11.76M	7.03M
Property-Plant & Equipment	19.88K	90.84K	187K	324K	436K	571K	693K	831K	993K	1.15M	1.25M
Goodwill & Intangibles	5.97M	5.64M	5.65M	5.65M	6.01M	2.94M	5K	6K	n/a	n/a	n/a
Total Long-Term Assets	5.99M	5.73M	5.83M	5.97M	6.44M	3.51M	698K	837K	993K	1.15M	1.25M
Total Assets	12.64M	18.15M	14.82M	14.78M	13.97M	10.54M	7.96M	5.53M	9.68M	12.91M	8.28M
Account Payables	1.64M	97K	1.41M	707K	1.69M	314K	1.76M	339K	1.28M	485K	2.04M
Deferred Revenue	n/a	571K	n/a	1.47M	n/a	926K	n/a	197K	n/a	n/a	n/a
Short-Term Debt	n/a	60.89K	501K	430K	174K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.12M	3.41M	564K	921K	1.62M	3.3M	364K	583K	198K	664K	1.67M
Total Current Liabilities	2.76M	6.12M	2.48M	5.03M	3.48M	5.57M	2.28M	1.9M	1.65M	1.84M	3.84M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	329K	643.87K	909K	1.31M	1.55M	n/a	-294	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	329K	643.87K	909K	1.42M	1.76M	295K	379.71K	463K	546K	620K	682K
Total Liabilities	3.09M	6.76M	3.39M	6.46M	5.24M	5.86M	2.66M	2.36M	2.19M	2.46M	4.52M
Total Debt	n/a	60.89K	501K	727K	382K	464K	544K	624K	713K	620K	812K
Book Value	9.55M	11.38M	11.44M	8.32M	8.73M	4.68M	5.3M	3.16M	7.49M	10.45M	3.75M
Book Value Per Share	0.51	0.10	0.91	2.49	5.32	7.86	106.85	1.28K	3.04K	4.25K	2.37K
Common Stock	14.16M	14.07M	61.56K	6.69M	3.63M	1.19M	277.97K	108.34K	98K	98K	63K
Retained Earnings	-103.97M	-102.62M	-154.13M	-150.42M	-147.88M	-144.77M	-138.97M	-135.34M	-130.76M	-127.8M	-125.55M
Comprehensive Income	172.95K	1.19M	67.77M	53M	61.74M	53M	53M	54.72M	54.72M	54.72M	54.72M
Shareholders Equity	9.55M	11.38M	11.44M	8.32M	8.73M	4.68M	5.3M	3.16M	7.49M	10.45M	3.75M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a